Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1149120190160010023
Journal of the Korean Society for Psoriasis
2019 Volume.16 No. 1 p.23 ~ p.26
Paradoxical pustular psoriasis induced by adalimumab in a patient with plaque psoriasis
An Ji-Hae

Shin Jung-U
Kim Hyun-Jung
Lee Hee-Jung
Yoon Moon-Soo
Kim Dong-Hyun
Abstract
Adalimumab is a monoclonal antibody that binds and inactivates tumor necrosis factor-¥á (TNF-¥á). Not infrequently, anti- TNF-¥á treatment can be associated with exacerbations and development of pathologic conditions that are considered to be responsive to TNF-¥á blockade, including psoriasiform reactions, flares of arthritis and inflammatory bowel, uveitis and other autoimmune diseases. This phenomenon is called ¡®paradoxical reaction¡¯. A 64-year-old man presented for erythematous scaly papules and pustules on his palms and soles, which had appeared initially 2 weeks ago. He had been treated with adalimumab for plaque psoriasis during the last 6 weeks and had no previous history of pustular psoriasis. After this episode, adalimumab was discontinued, and the patient started treatment with secukinumab. He also treated with oral cyclosporine 200 mg/day for 13 weeks at the same time, and most lesions disappeared completely. No evidence of recurrence has been observed during 1 year of follow up.
KEYWORD
Adalimumab, Anti-tumor necrosis factor-¥á, Paradoxical reaction, Pustular psoriasis
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)